Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia.
Tjitra E, Anstey NM, Sugiarto P, Warikar N, Kenangalem E, Karyana M, Lampah DA, Price RN. · 2008
Read Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. by Tjitra E, Anstey NM, Sugiarto P, Warikar N, Kenangalem E, Karyana M, Lampah DA, Price RN. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc2429950.txt.
Description
Tjitra and colleagues tracked malaria cases at a hospital in Papua, Indonesia, from 2004 to 2007 in this 2008 study. The region's malaria parasites resist many drugs, including the vivax species long dismissed as mild. The team recorded every outpatient and inpatient malaria case at the area's only hospital.
Malaria made up 16% of outpatient visits and 32% of admissions, with 60,226 outpatient cases in all. Among admitted patients, 22% had severe disease. Severe illness was actually more common in vivax infections, at 23%, than in falciparum infections, at 20%, and worst in mixed infections at 31% in this data. Severe anaemia, dangerously low red cell levels, drove most vivax complications. In children under one year, vivax caused 47% of malaria admissions. Overall 2.0% of admitted malaria patients died.
Catalog record
| CREATOR | Tjitra E, Anstey NM, Sugiarto P, Warikar N, Kenangalem E, Karyana M, Lampah DA, Price RN. |
|---|---|
| YEAR | 2008 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |